Crowdonomics
WatchlistPortfolio
All companies
CrowdMed, Inc. logo

CrowdMed, Inc.

Operating

Healthcare · San Francisco, CA

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$403,471
Across 1 round since 2016

Financials

FY2014–FY2019 · from SEC filings · hover any figure for its source
$125K
−$977K
2014
$283K
−$802K
2015
$125K
−$977K
2016
$283K
−$802K
2017
$133K
−$722K
2018
$128K
−$286K
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2014 reviewed*
FY2015 reviewed*
FY2016
FY2017
FY2018
FY2019
Income statement
Revenue
$124,862
$282,981
$124,862
$282,981
$133,262
$127,787
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
100%
100%
100%
100%
100%
100%
Net income
-$977,491
-$802,014
-$977,491
-$802,014
-$721,640
-$286,140
Taxes paid
$2,372
$2,464
$2,372
$2,464
$17,671
$9,472
Balance sheet
Cash
$827,900
$774,459
$827,900
$774,459
$376,702
$79,073
Accounts receivable
$0
$10,000
$0
$10,000
$10,000
$500
Total assets
$833,451
$789,678
$833,451
$789,678
$377,801
$92,751
Short-term debt
$38,652
$22,021
$38,652
$22,021
$13,006
$5,041
Long-term debt
$2,430,292
$3,195,292
$2,430,292
$3,195,292
$4,671,564
$4,671,564
Total liabilities
$2,468,944
$3,217,313
$2,468,944
$3,217,313
$4,684,570
$4,676,605
Other
Headcount
—
6
—
2
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · Convertible Note · Oct 2016Closedvia WeFunder
Raised $403.5K / $1M

Team

1 person
Jared Heyman
CEO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Possibly delinquent

Filed 2 of 10 annual reports (FY2016–FY2025)

Missing: 2016, 2018, 2020, 2021, 2022, 2023, 2024, 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARJun 8, 20200001670254-20-000425
    EDGAR
  • Form C-ARApr 27, 20180001670254-18-000165
    EDGAR
  • Form C-UDec 21, 20170001670254-17-000383
    EDGAR
  • Form C-UMay 8, 20170001670254-17-000107
    EDGAR
  • Form C/ANov 16, 20160001670254-16-000200
    EDGAR
  • Form COct 20, 20160001670254-16-000168
    EDGAR
Source: SEC EDGARCIK 0001687611DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.